Xeris Biopharma Holdings, Inc. (XERS)
Market Closed
3 Jun, 20:00
$
5. 89
-0.11
-1.8333%
$
1.08B Market Cap
- P/E Ratio
- Div Yield
1.15M Volume
-0.38 Eps
$ 6
Previous Close 
Want to track XERS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xeris Biopharma (XERS) Now Trades Above Golden Cross: Time to Buy?
From a technical perspective, Xeris Biopharma Holdings, Inc. (XERS) is looking like an interesting pick, as it just reached a key level of support. XERS's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.
Zacks | 1 year ago
Xeris Biopharma unveils CEO succession plan, John Shannon to lead company
Xeris Biopharma Holdings (NASDAQ:XERS) announced a CEO succession plan with John Shannon taking over from Paul Edick on August 1, 2024. Edick, the current CEO and chairman, will retire from his roles after more than seven years with the company.
Proactiveinvestors | 1 year ago
